These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15331975)

  • 1. [Long-term therapy in childhood epilepsy].
    Raffo E
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S272-9. PubMed ID: 15331975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment protocol for long-term anti-epilepsy drugs in children with refractory epilepsy].
    Dulac O; Chiron C
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S265-71. PubMed ID: 15331974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Criteria for treatment-resistant epilepsy: the neuro-pediatrician's position].
    Raffo E
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S48-52. PubMed ID: 15331948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-epileptic drugs indicated for the treatment by second intention of partial epilepsies].
    AFSSAPS
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S415-28. PubMed ID: 15331989
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment protocol for long-term anti-epilepsy drugs in adults with refractory partial epilepsy].
    Thomas P
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S252-64. PubMed ID: 15331973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical and medico-social case management of drug-resistant partial epilepsy. Specific implementation of long-term antiepileptic treatment in the adult].
    Chassagnon S
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S315-26. PubMed ID: 15331980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Refractory partial epilepsy: what are the neuropediatrician's criteria for drug resistance?].
    de Saint-Martin A; Hirsch E
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S43-7. PubMed ID: 15331947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The definition of drug resistance: an epileptologist's perspective].
    Genton P
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S53-9. PubMed ID: 15331949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug-resistant partial epilepsy: pharmacological criteria].
    Bordet R
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S36-42. PubMed ID: 15331946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eligibility for epilepsy surgery in children: review of the literature].
    Kaminska A
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S220-31. PubMed ID: 15331970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vagus nerve stimulation and refractory partial epilepsies].
    Landré E
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S280-7. PubMed ID: 15331976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of myoclonic epilepsies of childhood, adolescence, and adulthood.
    Medina MT; Martínez-Juárez IE; Durón RM; Genton P; Guerrini R; Dravet C; Bureau M; Perez-Gosiengfiao KT; Amador C; Bailey JN; Chaves-Sell F; Delgado-Escueta AV
    Adv Neurol; 2005; 95():307-23. PubMed ID: 15508934
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to carbamazepine in children with newly diagnosed partial onset epilepsy.
    Holland KD; Glauser TA
    Neurology; 2007 Aug; 69(6):596-9. PubMed ID: 17679679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of severity in partial intractable epilepsy].
    Remy C; Biraben A; Lavernhe G
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S65-70. PubMed ID: 15331951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
    Zhou B; Zhang Q; Tian L; Xiao J; Stefan H; Zhou D
    Epilepsy Behav; 2008 Feb; 12(2):305-10. PubMed ID: 18024209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.